Literature DB >> 31615824

Cost-effectiveness analysis should be mandatory in clinical-effectiveness research.

Bharath Kumar Tirupakuzhi Vijayaraghavan1, Xavier Willaert2, Brian H Cuthbertson3.   

Abstract

Mesh：

Year:  2019        PMID： 31615824      PMCID： PMC6791790          DOI： 10.1503/cmaj.73298

Source DB:  PubMed          Journal:  CMAJ        ISSN： 0820-3946            Impact factor:   8.262


× No keyword cloud information.
  7 in total

Review 1.  Design issues for conducting cost-effectiveness analyses alongside clinical trials.

Authors:  S D Ramsey; M McIntosh; S D Sullivan
Journal:  Annu Rev Public Health       Date:  2001       Impact factor: 21.981

2.  The limits of cost-effectiveness analysis.

Authors:  William S Weintraub; David J Cohen
Journal:  Circ Cardiovasc Qual Outcomes       Date:  2009-01

Review 3.  Cost-effectiveness analysis alongside clinical trials II-An ISPOR Good Research Practices Task Force report.

Authors:  Scott D Ramsey; Richard J Willke; Henry Glick; Shelby D Reed; Federico Augustovski; Bengt Jonsson; Andrew Briggs; Sean D Sullivan
Journal:  Value Health       Date:  2015-03       Impact factor: 5.725

4.  Embracing the science of value in health.

Authors:  Murray Krahn; Stirling Bryan; Karen Lee; Peter J Neumann
Journal:  CMAJ       Date:  2019-07-02       Impact factor: 8.262

5.  Assessment of the clinical effectiveness of pulmonary artery catheters in management of patients in intensive care (PAC-Man): a randomised controlled trial.

Authors:  Sheila Harvey; David A Harrison; Mervyn Singer; Joanne Ashcroft; Carys M Jones; Diana Elbourne; William Brampton; Dewi Williams; Duncan Young; Kathryn Rowan
Journal:  Lancet       Date:  2005 Aug 6-12       Impact factor: 79.321

6.  The incremental cost effectiveness of withdrawing pulmonary artery catheters from routine use in critical care.

Authors:  Katherine Stevens; Christopher McCabe; Carys Jones; Joanne Ashcroft; Sheila Harvey; Kathy Rowan
Journal:  Appl Health Econ Health Policy       Date:  2005       Impact factor: 2.561

7.  The PRaCTICaL study of nurse led, intensive care follow-up programmes for improving long term outcomes from critical illness: a pragmatic randomised controlled trial.

Authors:  B H Cuthbertson; J Rattray; M K Campbell; M Gager; S Roughton; A Smith; A Hull; S Breeman; J Norrie; D Jenkinson; R Hernández; M Johnston; E Wilson; C Waldmann
Journal:  BMJ       Date:  2009-10-16
  7 in total
  3 in total

1.  Economic evaluation alongside the Probiotics to Prevent Severe Pneumonia and Endotracheal Colonization Trial (E-PROSPECT): study protocol.

Authors:  Vincent Issac Lau; Deborah J Cook; Robert Fowler; Bram Rochwerg; Jennie Johnstone; François Lauzier; John C Marshall; John Basmaji; Diane Heels-Ansdell; Lehana Thabane; Feng Xie
Journal:  BMJ Open       Date:  2020-06-28       Impact factor: 2.692

2.  Cost-effectiveness of remdesivir plus usual care versus usual care alone for hospitalized patients with COVID-19: an economic evaluation as part of the Canadian Treatments for COVID-19 (CATCO) randomized clinical trial.

Authors:  Vincent I Lau; Robert Fowler; Ruxandra Pinto; Alain Tremblay; Sergio Borgia; François M Carrier; Matthew P Cheng; John Conly; Cecilia T Costiniuk; Peter Daley; Erick Duan; Madeleine Durand; Patricia S Fontela; George Farjou; Mike Fralick; Anna Geagea; Jennifer Grant; Yoav Keynan; Kosar Khwaja; Nelson Lee; Todd C Lee; Rachel Lim; Conar R O'Neil; Jesse Papenburg; Makeda Semret; Michael Silverman; Wendy Sligl; Ranjani Somayaji; Darrell H S Tan; Jennifer L Y Tsang; Jason Weatherald; Cedric Philippe Yansouni; Ryan Zarychanski; Srinivas Murthy
Journal:  CMAJ Open       Date:  2022-09-06

3.  Reality Check 2: The Cost-Effectiveness of Policy Disallowing Body Checking in Non-Elite 13- to 14-Year-Old Ice Hockey Players.

Authors:  Gillian R Currie; Raymond Lee; Luz Palacios-Derflingher; Brent Hagel; Amanda M Black; Shelina Babul; Martin Mrazik; Deborah A Marshall; Carolyn A Emery
Journal:  Int J Environ Res Public Health       Date:  2021-06-11       Impact factor: 3.390
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.